The emerging therapy of the medication represents a significant breakthrough in the care of type 2 diabetes. Different to existing therapies, tirzepatide affects two pathways – glucagon-like peptide-1 (GLP-1) and the https://tirzepatide-peptide234580.bloggosite.com/49989525/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment